Poseida Therapeutics, Inc. Temporary Equity, Liquidation Preference
Poseida Therapeutics, Inc. had Temporary Equity, Liquidation Preference of $326.31 million as of 2020-07-14, per its 10-K filed 2022-03-10.
Discontinued › Balance Sheet › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2022-03-10
- 2020-07-14: Temporary Equity, Liquidation Preference $326.31M.
- 2020-06-30: Temporary Equity, Liquidation Preference $326.31M.
- 2019-12-31: Temporary Equity, Liquidation Preference $222.17M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2020-07-14 | $326.31M 10-K · filed 2022-03-10 |
| 2020-06-30 | $326.31M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $222.17M 10-K · filed 2021-03-11 |